Exploring Hidden Issues in the Use of Antipsychotic Polypharmacy in the Treatment of Schizophrenia

The mainstay of schizophrenia treatment is pharmacological therapy using various antipsychotics including first- and second-generation antipsychotics which have different pharmacokinetic and pharmacodynamic property leading to differential presentation of adverse events (AEs) and treatment effects s...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jung-Jin, Pae, Chi-Un, Han, Changsu, Bahk, Won-Myong, Lee, Soo-Jung, Patkar, Ashwin A., Masand, Prakash S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553537/
https://www.ncbi.nlm.nih.gov/pubmed/34690115
http://dx.doi.org/10.9758/cpn.2021.19.4.600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553537/
https://www.ncbi.nlm.nih.gov/pubmed/34690115
http://dx.doi.org/10.9758/cpn.2021.19.4.600

Ejemplares similares